Results 101 to 110 of about 917,791 (305)

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients

open access: yesBMC Infectious Diseases, 2018
Background It is not fully explained why some active tuberculosis patients show negative interferon-γ release assays (IGRAs). In this study, we tried to explore associations of IGRAs with the characteristics of peripheral Vγ2Vδ2 T cells and their ...
Liping Yan, Hongbo Shen, Heping Xiao
doaj   +1 more source

Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To assess the efficacy and safety of deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, in patients with psoriatic arthritis (PsA) who were naive to biologic disease‐modifying antirheumatic drugs or received tumor necrosis factor inhibitors. Methods In the 52‐week (W), double‐blind, placebo‐controlled, phase 3 POETYK PsA‐2 study
Philip J. Mease   +20 more
wiley   +1 more source

Pleural Metastatic Melanoma with Refractory Hemorrhagic Effusion: A Case Report

open access: yesCancer Management and Research
Yuxiang Xu,1,* Kaixue Zhuang,1,* Weijian Liu,1 Peize Zhang,1 Hongjuan Qin,1 Taosheng Ye1,21Department of Pulmonary Medicine and Tuberculosis, The Third People’s Hospital of Shenzhen, Southern University of Science and Technology, Shenzhen,
Xu Y   +5 more
doaj  

Pharmacokinetic Bioequivalence and Safety Assessment of Two Venlafaxine Hydrochloride Extended-Release Capsules in Healthy Chinese Subjects Under Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Study

open access: yesDrugs in R&D
Background and Objective Venlafaxine hydrochloride extended-release (ER) capsules are commonly used to treat depression and anxiety disorders. Evaluation of the bioequivalence of generic formulations with reference products is essential to ensure ...
Yingxia He   +11 more
doaj   +1 more source

Associated factors for treatment delay in pulmonary tuberculosis in HIV-infected individuals: a nested case-control study. [PDF]

open access: yes, 2012
BACKGROUND: The delay in initiating treatment for tuberculosis (TB) in HIV-infected individuals may lead to the development of a more severe form of the disease, with higher rates of morbidity, mortality and transmissibility. The aim of the present study
Laura Cunha Rodrigues   +26 more
core   +2 more sources

Population pharmacokinetics of levofloxacin in breastmilk in patients with rifampicin‐resistant tuberculosis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Levofloxacin is a widely used antibiotic included in rifampicin‐resistant tuberculosis (RR‐TB) treatment. Data describing levofloxacin concentrations in breastmilk and infant exposure are limited. We analysed data from two South African studies of breastfeeding women receiving levofloxacin (750–1000 mg daily) for RR‐TB.
Sharon Sawe   +9 more
wiley   +1 more source

Critical role of molecular test in early diagnosis of gastric tuberculosis: a rare case report and review of literature

open access: yesBMC Infectious Diseases, 2019
Backgroud Early diagnosis of gastric tuberculosis is often challenging because the disease is very rare and its clinical manifestation is nonspecific and misleading. To raise the awareness and emphasize early diagnosis of gastric tuberculosis, we present
Jun Ma, Hongyun Yin, Huikang Xie
doaj   +1 more source

Pulmonary Tuberculosis [PDF]

open access: yesPulmonary Medicine, 2013
Anete Trajman   +3 more
openaire   +3 more sources

Plasma drug activity assay for treatment optimization in tuberculosis patients [PDF]

open access: yes, 2011
Item does not contain fulltextLow antituberculosis (TB) drug levels are common, but their clinical significance remains unclear, and methods of measurement are resource intensive.
Scott K. Heysell   +29 more
core   +1 more source

Home - About - Disclaimer - Privacy